Delivery Order SPE2DB22D1017-SPE2DB25FYPMF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,225.77 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $14,323.06 on August 13, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order...
- The Defense Logistics Agency awarded a $3,267.81 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens. The contract is a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and represents a child contract under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a $26,079.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,198.85 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $8,703.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens with a ceiling value of $1,290.88. This is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and represents a non-competed award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,431.03 delivery order on July 25, 2025, for Mounjaro 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,360.45 for Mounjaro 15 mg/0.5 ml pen injectors on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $1,568.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Mounjaro 10 mg/0.5 ml pens (0.5 ml units). This is a non-set-aside, competitively awarded contract with a completion date of August 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPMFDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $3,228.25 delivery order on August 29, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pens with a completion date of September 2, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning the award was competitively issued. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a broad spectrum of medical products to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Mounjaro is a diabetes medication used in military and veterans' healthcare systems. The delivery order represents a standard transaction within AmerisourceBergen's extensive portfolio of competitively awarded contracts with the DLA Medical Supply Chain, demonstrating the contractor's ongoing capability to fulfill federal pharmaceutical procurement requirements across multiple therapeutic domains and customer bases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/29/25 |